Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Ozeri

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Chemmedchem|August 8, 2006
Enzyme isoselective inhibitors: a tool for binding-trend analysisRachel Ozeri, Netaly Khazanov, Nurit Perlman, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2012
1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinaseAvihai Yacovan, Rachel Ozeri, Tzofit Kehat, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Chemmedchem|August 8, 2006
Enzyme isoselective inhibitors: a tool for binding-trend analysisRachel Ozeri, Netaly Khazanov, Nurit Perlman, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2012
1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinaseAvihai Yacovan, Rachel Ozeri, Tzofit Kehat, et al.
Pageof 1